Neurostimulation Devices Market Share

Statistics for the 2023 & 2024 Neurostimulation Devices market share, created by Mordor Intelligence™ Industry Reports. Neurostimulation Devices share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Neurostimulation Devices Industry

The neurostimulation devices market is fragmented in nature due to the presence of several companies operating globally. The key players adopt various strategies to maintain their market positions, such as acquisitions, partnerships, and heavy investments in research and development activities and new product launches. The major players include Abbott, Bayer AG, Boston Scientific Corporation, Laborie, LivaNova PLC, Neuronetics, NeuroPace Inc., Nevro Corp., Medtronic, and Synapse Biomedical Inc.

Neurostimulation Devices Market Leaders

  1. Boston Scientific Corporation

  2. Abbott

  3. Neuronetics

  4. Medtronic

  5. Bayer AG

*Disclaimer: Major Players sorted in no particular order

Neurostimulation Devices Market Concentration

Neurostimulation Devices Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)